ART Fertility Clinics Appoints David Jimenez To Board Of Directors

ART Fertility Clinics, a fertility services provider in the Middle East and India has appointed David Jimenez to its Board of Directors, the company informed in a press statement on Thursday.

The clinics have seen a swift expansion from their GCC roots into the Indian subcontinent, with plans to extend services further around the globe. David Jimenez served a decade-long tenure as CEO of Igenomix, an Advanced Molecular Diagnostics in the field of Reproductive Medicine.

David Jiminez said,“Joining the ART Fertility Clinics' Board of Directors is a privilege and an opportunity to contribute to a field that has a profound impact on people's lives. The clinic's dedication to excellence and its patient-first approach resonates deeply with my professional philosophy. I am eager to help ART continue its journey as a global leader in fertility care.”

Dr Karim El Solh, CEO of Gulf Capital and Chairman of Art Fertility, added: "David Jimenez's vision and leadership have been transformational in the healthcare sector. His experience in building Igenomix into a world leader in its field is invaluable. We look forward to welcoming him to the Art Fertility Board where he can bring a wealth of experience and help us accelerate the growth of our platform.”

Hazem Abu Khalaf, Managing Director at Gulf Capital, added, "We are delighted to have David join us on the board of ART Fertility. His addition underlines ART’s commitment to building a best-in-class organisation. Both Gulf Capital and ART’s management will benefit from his insights and his extensive international experience to accelerate ART Fertiltiy’s growth trajectory and further cement its position as the leading fertility treatment provider in the region."